- Home
- WST vs WAT Comparison
WST vs WAT Comparison
Compare WST & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WST
- WAT
- Stock Information
- Founded
- WST 1923
- WAT 1958
- Country
- WST United States
- WAT United States
- Employees
- WST N/A
- WAT N/A
- Industry
- WST Medical/Dental Instruments
- WAT Biotechnology: Laboratory Analytical Instruments
- Sector
- WST Health Care
- WAT Industrials
- Exchange
- WST Nasdaq
- WAT Nasdaq
- Market Cap
- WST 15.6B
- WAT 20.8B
- IPO Year
- WST N/A
- WAT 1995
- Fundamental
- Price
- WST $220.98
- WAT $289.69
- Analyst Decision
- WST Buy
- WAT Hold
- Analyst Count
- WST 7
- WAT 15
- Target Price
- WST $331.67
- WAT $379.27
- AVG Volume (30 Days)
- WST 615.3K
- WAT 696.1K
- Earning Date
- WST 07-24-2025
- WAT 08-04-2025
- Dividend Yield
- WST 0.38%
- WAT N/A
- EPS Growth
- WST N/A
- WAT 8.23
- EPS
- WST 6.37
- WAT 11.02
- Revenue
- WST $2,895,800,000.00
- WAT $2,983,253,000.00
- Revenue This Year
- WST $3.38
- WAT $6.11
- Revenue Next Year
- WST $5.82
- WAT $6.44
- P/E Ratio
- WST $34.74
- WAT $26.15
- Revenue Growth
- WST N/A
- WAT 2.57
- 52 Week Low
- WST $187.43
- WAT $287.62
- 52 Week High
- WST $352.33
- WAT $423.56
- Technical
- Relative Strength Index (RSI)
- WST 49.84
- WAT 23.06
- Support Level
- WST $219.60
- WAT $343.83
- Resistance Level
- WST $233.84
- WAT $360.00
- Average True Range (ATR)
- WST 5.32
- WAT 12.04
- MACD
- WST 0.04
- WAT -5.40
- Stochastic Oscillator
- WST 29.22
- WAT 3.35
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
About WAT Waters Corporation
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions.